Neoprobe gets grant to further Lymphoseek development

11/3/2010 | MarketWatch

Neoprobe has received a nearly $250,000 grant from the qualifying therapeutic discovery project program, which was developed under the health reform law. "This cash award will provide additional support for the development of Lymphoseek, our lead program, without diluting the value of either our assets or our equity," President and CEO David C. Bupp said.

View Full Article in:

MarketWatch

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ